Skip to Main Content

Paper Details

Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone <i>et al</i>.
Ann Rheum Dis
0
2023
Author NameAffiliation
Jean-Claude TardifResearch Centre, Montreal Heart Institute
  • 1 - 1

Datasets

Release 1.2